A61P 9 - Drugs for disorders of the cardiovascular system

Patents for A61P 9 - Drugs for disorders of the cardiovascular system (159,484)
12/2004
12/22/2004	CN1556810A Substituted 2-pyrimidinyl-6,7,8,9-tetrahydropyrimido[1,2-A]pyrimidin-4-one and 7-pyrimidinyl-2,3-dihydroimidazo[1,2-A]pyrimidin-5(1H)one derivatives for neurodegenerative disorders
12/22/2004	CN1556809A Substituted 2-pyridinyl-6,7,8,9-tetrahydropyrimido[1,2-A]pyrimidin-4-one and 7-pyridinyl-2,3-dihydroimidazo[1,2-A]pyrimidin-5(1H)one derivatives
12/22/2004	CN1556808A Heterocyclic compound based on N6-substituted adenine, methods of their preparation, their use for preparation of drugs, cosmetic preparations and growth regulators, pharmaceutical preparations, cosme
12/22/2004	CN1556805A Piperidine derivative as NMDA receptor antagonist
12/22/2004	CN1556804A 3-substituted-4-pyrimidone derivatives
12/22/2004	CN1556716A Modular infusion device and method
12/22/2004	CN1556707A Ophthalmologic treatment methods using selective iNOS inhibitors
12/22/2004	CN1556706A Thieno [1,3] oxazin-4-ones with lipase inhibiting activity
12/22/2004	CN1556705A 7,8,9,10-tetrahydro-6H-azepino, 6,7,8,9-tetrahydro-pyrido and 2,3-dihydro-2H-pyrrolo[2,1-b]-quinazolinone derivatives
12/22/2004	CN1556703A 1H-imidazole derivatives having CB1 agonistic, CB1 partial agonistic or CB1 antagonistic activity
12/22/2004	CN1556702A Aminoindazole derivatives active as kinase inhibitors, process for their preparation and pharmaceutical compositions containing them
12/22/2004	CN1556700A Methods for treating or preventing vascular inflammation using sterol absorption inhibitor(s)
12/22/2004	CN1556698A Neuroprotective treatment methods using selective iNOS inhibitors
12/22/2004	CN1556220A Antigen polypeptide of IC53 gene product, use of automatibody in diagonosis and treating of arrhythmia cardimyopathy and reagent kit containing the polypeptide
12/22/2004	CN1555889A Cellar air health care therapeutic agent
12/22/2004	CN1555887A Mineral composition and its manufacturing method
12/22/2004	CN1555875A Notoginseng ginkgo health care food and its preparation method
12/22/2004	CN1555873A Chinese herbal medicine for treating hypertension
12/22/2004	CN1555868A Chinese medicine for lowering blood pressure and its preparation method
12/22/2004	CN1555866A Medicine for treating congestion arhythmia and its preparation method
12/22/2004	CN1555864A Medicine for treating hypertension
12/22/2004	CN1555856A Musk willow flower distillate and its preparaton method
12/22/2004	CN1555854A Technological method of preparing vessels and networks quiet injection preparation
12/22/2004	CN1555843A Ginkgoleaf oral cavity disintegrating tablet and its preparation method
12/22/2004	CN1555839A Medicne for treating primary hypertension and its preparation method
12/22/2004	CN1555834A Medicinal composition containing salvia root effective component and ligusticum effecive component and its preparation
12/22/2004	CN1555826A Hemorrhoid preparation
12/22/2004	CN1555814A Extracting method of propolis effective component and its use
12/22/2004	CN1555811A Pearl lozenge
12/22/2004	CN1555807A Stability enhanced erigeron breviscapus injection and its preparation method
12/22/2004	CN1555806A Paeonoside injection and its preparation method and use
12/22/2004	CN1555803A Application of ferulaic acid chuanxiong rhizome qin in preparing medicine
12/22/2004	CN1555802A Cinnarizone self micro emulsified soft capsule and its preparation method
12/22/2004	CN1555801A Naipaidil slow release preparation
12/22/2004	CN1555797A Matrine oral slow release tablet and its preparation method
12/22/2004	CN1555792A Quke rutin granule agent and its preparation method
12/22/2004	CN1555791A Tanshinone II A sodium sulfonate powder injection agent and its preparation method
12/22/2004	CN1555790A Propyl gallate injection liquid and its preparation method
12/22/2004	CN1555789A Propyl gallate injection liquid and its preparation method
12/22/2004	CN1181095C Gene relative peptide derivant having calcitonin and preparation process thereof
12/22/2004	CN1181089C Prepn process of curcumol and oral medicine containing curcumol
12/22/2004	CN1181059C Quinoline-4-base derivative I
12/22/2004	CN1181050C Noval substituted dimeric compounds, its preparing process and medicinal composition containing same
12/22/2004	CN1181048C Aminobenzophenones as inhibitors of IL-1 beta and TNF_alpha
12/22/2004	CN1181046C Prepn process of chiral compound L-homophenproobamate and its salt
12/22/2004	CN1180832C Chinese medicine preparation for antihypertension and invigorating pulse
12/22/2004	CN1180822C Medicine for treating hemiparalysis, epilepsy, facial paralysis etc.
12/22/2004	CN1180821C Medicine for treating cerebral thrombus and its prepn process
12/22/2004	CN1180820C Tea for lowering blood pressure and its preparing process
12/22/2004	CN1180810C Medicine for curing encephalasthenia syndrome and its preparation method
12/22/2004	CN1180801C Magnetotherapeutic medicinal pad and its preparing process
12/22/2004	CN1180774C Use of rapamycin for preparing medicine for treating cardiac inflammatory disease
12/21/2004	US6833444 An erythromycin-type antibiotic based on a perhydro-oxazolo(5,4-c)oxacyclotetradecine ring; bactericides; antiprotazoa agents; non-polyene and ansa macrolide antibiotics
12/21/2004	US6833436 Short peptides which selectively modulate the activity of serine/threonine kinases
12/21/2004	US6833380 Compounds that modulate PPAR activity and methods of preparation
12/21/2004	US6833379 As diuretic agent
12/21/2004	US6833378 Pyridines, pyrimidines, purinones, pyrrolopyrimidinones and pyrrolopyridinones; useful in the treatment disorders including CNS and stress-related disorders.
12/21/2004	US6833376 5-aminoalkyl and 5-aminocarbonyl substituted indole derivative useful for treatment of psychosis in a mammal
12/21/2004	US6833366 Alpha v beta 3 and/or 5 integrin antagonists; reduced side effects
12/21/2004	US6833364 Inhibiting degradation of cyclic guanosine monophosphate; cardiovascular disorders; such as 3-(4-amino-5-cyclopropyl-pyrimidin-2-yl)-1-(2-fluorobenzyl)1H-pyrazolo-(3,4 -b)-pyridine
12/21/2004	US6833363 N-sulphated hyaluronic acid compounds, derivatives thereof and a process for their preparation
12/21/2004	US6833269 Stem cell culture product
12/21/2004	US6833243 For diagnosis of psychosis/schizophrenia via detection of mutant allele
12/21/2004	CA2317604C Matrix metalloprotease inhibitors
12/21/2004	CA2140649C Hybrid oligonucleotide phosphorothioates
12/21/2004	CA2134674C Gaba and l-glutamic acid analogs for antiseizure treatment
12/16/2004	WO2004108928A1 Cholesterol biosynthesis pathway modulators and uses thereof
12/16/2004	WO2004108923A1 Cd47 partal peptdie and anti-shps-1 monoclonal antibody
12/16/2004	WO2004108907A1 Nerve cell obtained by electrically pulse-treating es cell
12/16/2004	WO2004108708A1 3-substituted indoles and derivatives thereof as therapeutic agents
12/16/2004	WO2004108661A1 Amidino compounds as cysteine protease inhibitors
12/16/2004	WO2004108167A1 Plasmid encoding fibroblast growth factor for the treatment of hypercholesterolemia or diabetes associated angiogenic defects
12/16/2004	WO2004108163A1 Method for preparing powder exhibiting low susceptibility to electrification
12/16/2004	WO2004108161A1 Solid pharmaceutical preparation
12/16/2004	WO2004108129A1 Stem cell invasion inhibitor
12/16/2004	WO2004108064A2 Diosgenin-based composition suitable for topical application
12/16/2004	WO2004108062A2 Prophylaxis and/or treatment of portal hypertension
12/16/2004	WO2004073602A3 Aldosterone blocker therapy to prevent or treat inflammation-related disorders
12/16/2004	WO2004010951A3 Method of treating tumors
12/16/2004	WO2003105908B1 Methods and compositions using cellular asialodeterminants and glycoconjugates for targeting cells to tissues and organs
12/16/2004	WO2003090684A8 Polymer compositions containing a macrocyclic triene compound
12/16/2004	US20040254385 Process for the preparation of citalopram hydrobromide
12/16/2004	US20040254382 Imidazolyl derivatives as corticotropin releasing factor inhibitors
12/16/2004	US20040254376 Cyclic amidine derivative
12/16/2004	US20040254370 Peroxisome proliferators activated receptor regulator; useful for hypoglycemia, hypolipidemia, preventing and/or treatment of diseases associating metabolic disorders, atherosclerosis, cardiovascular diseases, syndrome x, cholestrol
12/16/2004	US20040254362 Nucleotide sequences coding polypeptide associate with fatty acid metabolism for use in diagnosis, prevention and treatment of obesity, diabetes and heart disease
12/16/2004	US20040254350 Immunomodulatory protein for use in diagnosis, treatment, and prevention of immune system, neurological, developmental, muscle and cell proliferative disorders
12/16/2004	US20040254249 Nonsteroidal antiinflammatory agents
12/16/2004	US20040254240 Anti-cancer nitro- and thia-fatty acids
12/16/2004	US20040254233 Pyrazolidinone compounds as ligands of the prostaglandin ep2 and/or ep4 receptors
12/16/2004	US20040254224 Medicaments
12/16/2004	US20040254223 Process for the preparation of amorphous form of torsemide
12/16/2004	US20040254216 Inhibitors of p38
12/16/2004	US20040254213 Use of bicyclo compounds for treating alzheimer's disease
12/16/2004	US20040254212 Naphthyridine derivatives, their preparation and their use as phosphodiesterase isoenzyme 4 (pde4) inhibitors
12/16/2004	US20040254211 Alpha v integrin receptor antagonists
12/16/2004	US20040254203 Methods and compositions utilizing quinazolinones
12/16/2004	US20040254200 Antiinflammatory agents; controlling interleukins, tumor necrosis factor; antiarthritic agents; immunosuppressants
12/16/2004	US20040254198 Respiratory system disorders; asthma; chronic obstructive pulmonary disease
12/16/2004	US20040254192 2,4,5-trisubstituded thiazolyl derivatives and their antiinflammatory activity

1 ... 828 829 830 831 832 833 834 835 836 837 838 839 840 841 842 843 844 845 846 847 848 ... 1595